Diffuse Large B-Cell Lymphoma (Non-Hodgkin Lymphoma) Staging

1. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016 May 19. 127 (20):2375-90. [QxMD MEDLINE Link]. [Full Text].

2. [Guideline] National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: B-Cell Lyphomas. Available at https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf. Version 6.2023 — October 10, 2023; Accessed: October 26, 2023.

3. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993 Sep 30. 329(14):987-94. [QxMD MEDLINE Link].

Francisco J Hernandez-Ilizaliturri, MD Professor of Medicine, Department of Medical Oncology, Associate Professor of Immunology, Department of Immunology, Chief, Lymphoma and Myeloma Section, Director, The Lymphoma Translational Research Program, Roswell Park Cancer Institute, University of Buffalo State University of New York School of Medicine and Biomedical Sciences

Francisco J Hernandez-Ilizaliturri, MD is a member of the following medical societies: American Association for Cancer Research, American Society of Hematology

Disclosure: Nothing to disclose.

Jasmeet Anand, PharmD, RPh Adjunct Instructor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Christopher D Braden, DO Hematologist/Oncologist, Chancellor Center for Oncology at Deaconess Hospital; Medical Director, Deaconess Hospital Outpatient Infusion Centers; Chairman, Deaconess Hospital Cancer Committee

Christopher D Braden, DO is a member of the following medical societies: American Society of Clinical Oncology, American Society of Hematology

Disclosure: Nothing to disclose.

Matthew C Foster, MD Associate Professor of Medicine, Division of Hematology, Program Leader of Leukemia, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine

Matthew C Foster, MD is a member of the following medical societies: American Society of Clinical Oncology, American Society of Hematology, Leukemia and Lymphoma Society, North Carolina Oncology Association

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Daiichi Sankyo; Zentalis Pharmaceuticals<br/>Received research grant from: Bellicum Pharmaceuticals; Macrogenics; Rafael Pharmaceuticals; Loxo/Lilly Oncology; Newave Pharmaceuticals.

• Print this section
• Print the entire contents of
• Print the entire contents of article